Global Pharmaceutical
This article was originally published in The Tan Sheet
Executive Summary
President Barry Edwards promoted to CEO and elected to the board of the Philadelphia OTC and Rx generic drug firm. He succeeds Max Mendelsohn, who has served as CEO since Global went public in December 1995. Mendelsohn will stay on as non-executive chairman. Barry joined the firm in April 1998 after working at the generics firm Teva for 21 years, where his last post was as VP-marketing and business development